EuBiologics Co., Ltd. (KOSDAQ:206650)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,410
-240 (-1.90%)
Oct 30, 2025, 3:30 PM KST
-1.90%
Market Cap463.30B
Revenue (ttm)96.04B
Net Income (ttm)24.87B
Shares Out36.62M
EPS (ttm)n/a
PE Ratio18.63
Forward PE10.07
Dividendn/a
Ex-Dividend Daten/a
Volume304,767
Average Volume161,638
Open12,550
Previous Close12,650
Day's Range12,320 - 12,640
52-Week Range10,000 - 18,800
Beta0.46
RSI35.08
Earnings DateOct 28, 2025

About EuBiologics

EuBiologics Co., Ltd., a biopharmaceutical company, focuses on developing vaccines against global pandemic and bacterial vaccines primarily in South Korea. It offers inactivated oral cholera vaccine under the Euvichol, Euvichol-Plus, and Euvichol-S names; and EuCorVac-19, a recombinant protein vaccine. The company also provides EcML that is used as a vaccine adjuvant, directly activating antigen presenting cell expressing TLR 4 agonist, stimulating the production of cytokines and co-stimulatory molecules. In addition, it offers carrier protein ... [Read more]

Sector Healthcare
Founded 2010
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 206650
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.